Values, preferences and burden of treatment for the initiation of GLP-1 receptor agonists and SGLT-2 inhibitors in adult patients with type 2 diabetes: a systematic review

por González González, José Gerardo, Díaz González Colmenero, Alejandro, Millán Alanís, Juan Manuel, Lytvyn, Lyubov, Solís, Ricardo Cesar, Mustafa, Reem A, Palmer, Suetonia C, Li, Sheyu, Hao, Qiukui, Alvarez Villalobos, Neri Alejandro, Vandvik, Per Olav, Rodríguez Gutiérrez, René
Publicado 2021